There’s a new sense of excitement surrounding Vallon Pharmaceuticals Inc. (VLON)

Vallon Pharmaceuticals Inc. (NASDAQ: VLON) closed the day trading at 0.36 up 8.11% from the previous closing price of $0.33. In other words, the price has increased by $+0.0271 from its previous closing price. On the day, 1138981 shares were traded. VLON reached its highest trading level at $0.3945 during the session, while it also had its lowest trading level at $0.2850.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Ratios:

For a better understanding of VLON, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Stock Price History:

Over the past 52 weeks, VLON has reached a high of $8.54, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is 0.4229, while the 200-Day Moving Average is calculated to be 2.6879.

Shares Statistics:

Over the past 3-months, VLON traded about 474.22K shares per day on average, while over the past 10 days, VLON traded about 360.76k shares per day. A total of 8.68M shares are outstanding, with a floating share count of 5.58M. Insiders hold about 0.40% of the company’s shares, while institutions hold 21.50% stake in the company. Shares short for VLON as of Jul 14, 2022 were 140.33k with a Short Ratio of 0.27, compared to 29.93k on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.33% and a Short% of Float of 2.54%.

Earnings Estimates

Current recommendations for the stock of the company come from 0 analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.